E139: Customer Support AI, Clinical Documentation AI, and Helicopter Ubers

Our Social Media Pages, follow us and engage with the Pill-grim community! Join our Entre Community Instagram Twitter  YouTube TikTok LinkedIn  And now for this week’s prescription: On this week’s dose, we start (1:58) with a breakdown on Decagon, an enterprise AI platform revolutionizing customer support, following their $65M Series B. Next (9:28), we dive into Abridge, a startup using AI to automate clinical documentation, backed by a recent $250M funding round. Finally (20:11) , we wrap up with a deep dive on Joby, a company developing electric air taxis for commercial passenger service, and their additional $500M investment from Toyota. Sources: https://decagon.ai/blog/series-b  https://www.abridge.com/ https://techcrunch.com/2024/06/18/how-abridge-became-one-of-the-most-talked-about-healthcare-ai-startups/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAALhF6BSj0lyZwC64cw-YB1qSaFwsl5fQBx9Q15snKLTn2J02SNzvontN6PVuSKRJiBNRZTx61UXxAzv1BC5UVLOBujaKES08ovmk859Z28za0j9HZNYL4GwEwzB-7hXaKMgjPJG1-M8ms6wXR2XcVdi1v32hX_3OaFoJBQ5VQlv0  https://siliconangle.com/2024/10/11/healthcare-ai-startup-abridge-reportedly-raising-250m-2-5b-valuation/ https://www.beckershospitalreview.com/digital-health/abridge-raising-250m-report.html https://www.jobyaviation.com/ https://pressroom.toyota.com/toyota-to-invest-500-million-in-joby-aviation/ Music Credit: Chapter One by Cole Bauer and Dean Keeton https://www.instagram.com/deankeeton/?hl=en Disclosure: The views, statements, and opinions,  expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.